ProMIS Neurosciences Inc(PMN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PMN ProMIS Neurosciences Inc

未开盘 08-27 16:00:00 EDT

13.99

-0.47

-3.25%

盘后14.30

+0.31+2.22%

19:54 EDT

最高15.19	最低13.92	成交量1.81万
今开14.62	昨收14.46	日振幅8.78%
总市值1.25亿	流通市值6,140万	总股本896.77万
成交额26.34万	换手率0.41%	流通股本438.91万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PMN","market":"US","secType":"STK","nameCN":"ProMIS Neurosciences Inc","latestPrice":13.99,"timestamp":1787860800000,"preClose":14.46,"halted":0,"volume":18125,"hourTrading":{"tag":"盘后","latestPrice":14.3,"preClose":13.99,"latestTime":"19:54 EDT","volume":875,"amount":12406.8631,"timestamp":1787874845746,"change":0.31,"changeRate":0.022159,"amplitude":0.022159},"delay":0,"changeRate":-0.03250345781466118,"floatShares":4389100,"shares":8967700,"eps":-12.62,"marketStatus":"未开盘","change":-0.47,"latestTime":"08-27 16:00:00 EDT","open":14.62,"high":15.19,"low":13.92,"amount":263431.160625,"amplitude":0.087828,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-12.62,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787904000000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":14.46,"postHourTrading":{"tag":"盘后","latestPrice":14.3,"preClose":13.99,"latestTime":"19:54 EDT","volume":875,"amount":12406.8631,"timestamp":1787874845746,"change":0.31,"changeRate":0.022159,"amplitude":0.022159},"volumeRatio":0.585221},"requestUrl":"/m/hq/s/PMN","defaultTab":"news","newsList":[{"id":"1103516348","title":"ProMIS Neurosciences发布2026年第二季度财报，并披露公司战略亮点","url":"https://stock-news.laohu8.com/highlight/detail?id=1103516348","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103516348?lang=zh_cn&edition=full","pubTime":"2026-08-14 04:01","pubTimestamp":1786651269,"startTime":"0","endTime":"0","summary":"ProMIS Neurosciences Inc（简称PMN）今日正式对外公布了其2026年第二季度的财务业绩，同时就公司近期取得的重大进展与战略方向进行了详细阐述。\n这份财报不仅展示了公司在该季度的财务表现，更折射出其在神经科学领域持续深耕的决心。通过一系列关键指标与里程碑事件的披露，管理层向市场传递了积极信号，彰显了企业在研发管线推进与运营效率提升方面的双重成果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188710372","title":"ProMIS Neurosciences：中期分析显示，所有基因型（包括ApoE4纯合子）均未观察到Aria-E","url":"https://stock-news.laohu8.com/highlight/detail?id=1188710372","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188710372?lang=zh_cn&edition=full","pubTime":"2026-07-28 18:07","pubTimestamp":1785233259,"startTime":"0","endTime":"0","summary":"ProMIS Neurosciences公司公布的中期分析结果令人瞩目。数据显示，在所有受试者的基因型中——甚至包括ApoE4纯合子这一高风险群体——均未观察到Aria-E现象。这一发现无疑为相关疗法的安全性提供了有力佐证。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129598347","title":"Chardan Capital Markets首次覆盖ProMIS Neurosciences，给予买入评级，目标价20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1129598347","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129598347?lang=zh_cn&edition=full","pubTime":"2026-07-27 10:43","pubTimestamp":1785120190,"startTime":"0","endTime":"0","summary":"Chardan Capital Markets正式启动对ProMIS Neurosciences Inc的覆盖研究，给予该股“买入”评级，并设定20美元的目标价。这一举措，无疑为这家专注于神经科学领域的公司注入了新的市场关注度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157954956","title":"ProMIS Neurosciences公布2026年第一季度财务业绩并更新公司动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1157954956","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157954956?lang=zh_cn&edition=full","pubTime":"2026-05-12 18:32","pubTimestamp":1778581941,"startTime":"0","endTime":"0","summary":"ProMIS Neurosciences Inc（PMN）近日发布了其2026年第一季度的财务报告，同时概述了公司在报告期内的关键业务进展与战略重点。此次披露为投资者提供了关于公司财务状况与研发管线推进情况的最新视角。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618134563","title":"Promis Neurosciences Inc.盘中异动 急速下挫6.64%报20.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618134563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2618134563?lang=zh_cn&edition=full","pubTime":"2026-03-11 23:34","pubTimestamp":1773243263,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日23时34分，Promis Neurosciences Inc.股票出现波动，股价急速下跌6.64%。截至发稿，该股报20.25美元/股，成交量1.4975万股，换手率0.70%，振幅8.39%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.65%。其相关个股中，Acurx Pharmaceuticals, Inc.、Kala Bio, Inc.、Ocugen, Inc.涨幅较大，Acurx Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.、Quince Therapeutics, Inc.较为活跃，换手率分别为1920.80%、1036.25%、65.89%，振幅较大的相关个股有Acurx Pharmaceuticals, Inc.、天演药业、Kala Bio, Inc.，振幅分别为62.07%、56.62%、50.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311233423a461a532&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311233423a461a532&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","ARFXF","BK4139","PMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517574941","title":"Promis Neurosciences Inc.盘中异动 早盘急速上涨6.55%报0.830美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517574941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517574941?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:57","pubTimestamp":1741190237,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时57分，Promis Neurosciences Inc.股票出现波动，股价大幅上涨6.55%。截至发稿，该股报0.830美元/股，成交量7251股，换手率0.02%，振幅3.90%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为1.50%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305235717963af135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305235717963af135&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXF","PMN","ARFXD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516598456","title":"Promis Neurosciences Inc.盘中异动 快速跳水12.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516598456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516598456?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:25","pubTimestamp":1741022716,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日01时25分，Promis Neurosciences Inc.股票出现异动，股价急速下跌12.56%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Alto Neuroscience, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为4182.16%、177.33%、156.20%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304012516abe667ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304012516abe667ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","BK4139","PMN","ARFXD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514238270","title":"Promis Neurosciences Inc.盘中异动 早盘股价大跌6.49%报0.720美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514238270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514238270?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:04","pubTimestamp":1740672240,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时04分，Promis Neurosciences Inc.股票出现波动，股价急速下跌6.49%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228000401abdf857d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228000401abdf857d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","BK4139","PMN","ARFXD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512847534","title":"Promis Neurosciences Inc.盘中异动 股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512847534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512847534?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:36","pubTimestamp":1739983009,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时36分，Promis Neurosciences Inc.股票出现异动，股价急速下跌5.41%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003649a24c12fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003649a24c12fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMN","ARFXD","BK4139","ARFXF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511452508","title":"Promis Neurosciences Inc.盘中异动 早盘股价大涨9.63%报1.000美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511452508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511452508?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457063,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，Promis Neurosciences Inc.股票出现异动，股价大幅拉升9.63%。截至发稿，该股报1.000美元/股，成交量2363股，换手率0.01%，振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223103abcdb1d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223103abcdb1d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","PMN","BK4139","ARFXD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509220600","title":"Promis Neurosciences Inc.盘中异动 大幅上涨5.91%报0.985美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509220600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509220600?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:37","pubTimestamp":1738859853,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时37分，Promis Neurosciences Inc.股票出现异动，股价急速上涨5.91%。截至发稿，该股报0.985美元/股，成交量6992股，换手率0.02%，振幅3.23%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003733987ca217&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003733987ca217&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","ARFXD","PMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507624281","title":"Promis Neurosciences Inc.盘中异动 早盘股价大涨5.12%报0.940美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507624281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507624281?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:49","pubTimestamp":1738248549,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时49分，Promis Neurosciences Inc.股票出现波动，股价急速拉升5.12%。截至发稿，该股报0.940美元/股，成交量2028股，换手率0.01%，振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302249099876b3dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302249099876b3dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXF","ARFXD","PMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506305280","title":"Promis Neurosciences Inc.盘中异动 股价大涨10.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506305280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506305280?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:50","pubTimestamp":1737989421,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时50分，Promis Neurosciences Inc.股票出现波动，股价急速上涨10.75%。截至发稿，该股报0.990美元/股，成交量2320股，换手率0.01%，振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为1.09%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127225022a2316ef3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127225022a2316ef3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMN","ARFXD","ARFXF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505049965","title":"Promis Neurosciences Inc.盘中异动 股价大涨5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505049965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505049965?lang=zh_cn&edition=full","pubTime":"2025-01-24 01:24","pubTimestamp":1737653081,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日01时24分，Promis Neurosciences Inc.股票出现波动，股价大幅拉升5.85%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.77%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124012441a22d2d07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124012441a22d2d07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","BK4139","PMN","ARFXF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505577065","title":"Promis Neurosciences Inc.盘中异动 快速下跌5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505577065","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505577065?lang=zh_cn&edition=full","pubTime":"2025-01-23 03:30","pubTimestamp":1737574235,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日03时30分，Promis Neurosciences Inc.股票出现波动，股价大幅跳水5.97%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123033035960d2e12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123033035960d2e12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXF","PMN","ARFXD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505542272","title":"Promis Neurosciences Inc.盘中异动 早盘大幅拉升8.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505542272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505542272?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:33","pubTimestamp":1737469987,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时33分，Promis Neurosciences Inc.股票出现波动，股价急速拉升8.98%。截至发稿，该股报0.970美元/股，成交量5797股，换手率0.02%，振幅6.18%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223307960bb946&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223307960bb946&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PMN","ARFXD","ARFXF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503915753","title":"Promis Neurosciences Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503915753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503915753?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:01","pubTimestamp":1737039711,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时01分，Promis Neurosciences Inc.股票出现异动，股价快速上涨5.10%。截至发稿，该股报0.960美元/股，成交量1958股，换手率0.01%，振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.91%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116230151abad56fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116230151abad56fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","ARFXF","BK4139","PMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503110640","title":"Promis Neurosciences Inc.盘中异动 早盘股价大跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503110640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503110640?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:53","pubTimestamp":1736952783,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时53分，Promis Neurosciences Inc.股票出现波动，股价快速下挫5.50%。截至发稿，该股报0.890美元/股，成交量1.3754万股，换手率0.04%，振幅1.43%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115225304ababf80e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115225304ababf80e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","BK4139","ARFXF","PMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503574540","title":"Promis Neurosciences Inc.盘中异动 早盘急速下挫5.00%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503574540","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503574540?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:38","pubTimestamp":1736865480,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时38分，Promis Neurosciences Inc.股票出现异动，股价急速下跌5.00%。截至发稿，该股报0.950美元/股，成交量551股，换手率0.00%，振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011422380096038152&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011422380096038152&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","BK4139","PMN","ARFXD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.promisneurosciences.com","stockEarnings":[{"period":"1week","weight":-0.0617},{"period":"1month","weight":-0.0365},{"period":"3month","weight":0.2942},{"period":"6month","weight":-0.4049},{"period":"1year","weight":0.0491},{"period":"ytd","weight":1.0498}],"compareEarnings":[{"period":"1week","weight":0.0111},{"period":"1month","weight":0.0408},{"period":"3month","weight":0.0193},{"period":"6month","weight":0.1241},{"period":"1year","weight":0.1925},{"period":"ytd","weight":0.1308}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ProMIS Neurosciences Inc.根据加拿大商业公司法于2004年1月23日成立。该公司已获得一项专利技术平台的授权，专注于开发针对神经退行性疾病及其他错误折叠蛋白疾病的抗体疗法和治疗性疫苗。其平台旨在选择性靶向与阿尔茨海默病、帕金森病和肌萎缩侧索硬化等疾病相关的毒性错误折叠蛋白。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.492325},{"month":2,"riseRate":0.5,"avgChangeRate":0.1186},{"month":3,"riseRate":0,"avgChangeRate":-0.161081},{"month":4,"riseRate":0.5,"avgChangeRate":0.06597},{"month":5,"riseRate":0,"avgChangeRate":-0.137867},{"month":6,"riseRate":0.25,"avgChangeRate":-0.061162},{"month":7,"riseRate":0.5,"avgChangeRate":0.083188},{"month":8,"riseRate":0.2,"avgChangeRate":-0.14452},{"month":9,"riseRate":0.5,"avgChangeRate":-0.048217},{"month":10,"riseRate":0.25,"avgChangeRate":-0.042317},{"month":11,"riseRate":0,"avgChangeRate":-0.242658},{"month":12,"riseRate":0.5,"avgChangeRate":-0.058437}],"exchange":"NASDAQ","name":"ProMIS Neurosciences Inc","nameEN":"ProMIS Neurosciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ProMIS Neurosciences Inc(PMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ProMIS Neurosciences Inc(PMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ProMIS Neurosciences Inc,PMN,ProMIS Neurosciences Inc股票,ProMIS Neurosciences Inc股票老虎,ProMIS Neurosciences Inc股票老虎国际,ProMIS Neurosciences Inc行情,ProMIS Neurosciences Inc股票行情,ProMIS Neurosciences Inc股价,ProMIS Neurosciences Inc股市,ProMIS Neurosciences Inc股票价格,ProMIS Neurosciences Inc股票交易,ProMIS Neurosciences Inc股票购买,ProMIS Neurosciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ProMIS Neurosciences Inc(PMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ProMIS Neurosciences Inc(PMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}